Aveanna Healthcare (AVAH) Scheduled to Post Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH – Get Rating) is scheduled to post its quarterly earnings results before the market opens on Thursday, March 16th. Analysts expect Aveanna Healthcare to post earnings of ($0.02) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Aveanna Healthcare Stock Up 9.7 %

Shares of NASDAQ:AVAH opened at $1.59 on Thursday. Aveanna Healthcare has a 12 month low of $0.67 and a 12 month high of $6.00. The company’s 50-day moving average price is $1.16 and its two-hundred day moving average price is $1.25. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 5.63. The firm has a market cap of $295.61 million, a P/E ratio of -0.54 and a beta of 0.79.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Atria Wealth Solutions Inc. bought a new position in shares of Aveanna Healthcare in the first quarter valued at $91,000. Price T Rowe Associates Inc. MD boosted its position in Aveanna Healthcare by 54.5% during the third quarter. Price T Rowe Associates Inc. MD now owns 59,518 shares of the company’s stock worth $90,000 after purchasing an additional 21,000 shares during the period. Envestnet Asset Management Inc. boosted its position in Aveanna Healthcare by 15.7% during the first quarter. Envestnet Asset Management Inc. now owns 26,363 shares of the company’s stock worth $90,000 after purchasing an additional 3,569 shares during the period. LPL Financial LLC bought a new position in Aveanna Healthcare during the second quarter worth $81,000. Finally, Cubist Systematic Strategies LLC bought a new position in Aveanna Healthcare during the second quarter worth $68,000. 91.65% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on AVAH. Credit Suisse Group downgraded shares of Aveanna Healthcare from a “neutral” rating to an “underperform” rating and cut their target price for the company from $2.00 to $1.00 in a research report on Friday, January 27th. Royal Bank of Canada downgraded shares of Aveanna Healthcare from an “outperform” rating to a “sector perform” rating and cut their target price for the company from $7.00 to $3.00 in a research report on Monday, November 21st. Truist Financial cut their price target on shares of Aveanna Healthcare to $1.25 in a research report on Wednesday, November 16th. Finally, Stephens cut their price target on shares of Aveanna Healthcare from $2.25 to $1.50 and set an “equal weight” rating on the stock in a research report on Friday, November 11th. Two analysts have rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.14.

About Aveanna Healthcare

(Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.